申请人:PFAU Roland
公开号:US20130303571A1
公开(公告)日:2013-11-14
The present invention relates to compounds of general formula I
in which A, L, M, Q
2
, Q
3
, Q
4
, R
1
, R
5
, R
a
, R
b
, R
c
, W, X, Y, Z
1
, Z
2
, Z
3
are defined in the description, the salts thereof, particularly the physiologically acceptable salts thereof. The compounds are of potential utility in the treatment and/or prevention of inflammatory diseases and associated conditions, in particular, in the treatment and/or prevention of pain. The invention also relates to the use of such compounds as medicaments, to pharmaceutical compositions containing them, and to their preparation.
本发明涉及一般式I的化合物,其中A、L、M、Q2、Q3、Q4、R1、R5、Ra、Rb、Rc、W、X、Y、Z1、Z2、Z3在说明书中有定义,以及其盐,特别是生理上可接受的盐。这些化合物在治疗和/或预防炎症性疾病和相关症状方面具有潜在的用途,特别是在治疗和/或预防疼痛方面。本发明还涉及将这些化合物用作药物、含有它们的制药组合物以及它们的制备。